1. Home
  2. FIXX

FIXX

Homology Medicines Inc.

Logo Homology Medicines Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-02-2024 10:34am EST

$
-
.
-
-
-
$
-
-
.
-
-
-
-
-
.
-
-
%

Homology Medicines Inc is a United States-based genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a range of genetic disorders.

Founded: 2015 Country:
United States
United States
Employees: N/A City: BEDFORD
Market Cap: 53.9M IPO Year: N/A
Target Price: $7.63 AVG Volume (30 days): 27.6K
Analyst Decision: Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.95 EPS Growth: N/A
52 Week Low/High: $0.90 - $26.64 Next Earning Date: 03-13-2024
Revenue: $1,156,000 Revenue Growth: -63.97%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: